Skip to main content

Table 2 Correlation between AURKA expression level and clinical features in 49 GIST patients

From: Aurora kinase A (AURKA) promotes the progression and imatinib resistance of advanced gastrointestinal stromal tumors

Parameter Characteristic No. patients (%) AURKA score Statistics P value
Gender Female 23 (46.9) 1.93 ± 1.35 t = − 0.430 0.669
Male 26 (53.1) 2.12 ± 1.52   
Age < 57 24 (49.0) 2.05 ± 1.52 t = − 0.121 0.904
≥ 57 25 (51.0) 2.00 ± 1.36   
Location Stomach 14 (28.6) 1.74 ± 1.30  F = 1.321 0.277
Small intestine 12 (24.5) 1.68 ± 1.30   
Large intestine 23 (46.9) 2.37 ± 1.53   
Risk* High 18 (36.7) 2.02 ± 1.43  F = 35.449 < 0.001
Intermediate 4 (8.2) 2.1 ± 1.29   
Low 20 (40.8) 1.26 ± 0.74   
Very low 7 (14.3) 0.40 ± 0.52   
  1. *P < 0.05 was considered statistically significant